nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0743	0.0957	CbGbCtD
Pimozide—CYP3A7—Dexamethasone—psoriatic arthritis	0.0576	0.0741	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0576	0.0741	CbGbCtD
Pimozide—CYP2C19—Prednisone—psoriatic arthritis	0.0558	0.0718	CbGbCtD
Pimozide—CYP2E1—Dexamethasone—psoriatic arthritis	0.0556	0.0716	CbGbCtD
Pimozide—ABCB1—Betamethasone—psoriatic arthritis	0.0483	0.0622	CbGbCtD
Pimozide—ABCB1—Prednisolone—psoriatic arthritis	0.0477	0.0614	CbGbCtD
Pimozide—ABCB1—Prednisone—psoriatic arthritis	0.045	0.058	CbGbCtD
Pimozide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0445	0.0573	CbGbCtD
Pimozide—CYP3A5—Dexamethasone—psoriatic arthritis	0.0432	0.0556	CbGbCtD
Pimozide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0348	0.0449	CbGbCtD
Pimozide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0337	0.0434	CbGbCtD
Pimozide—CYP3A4—Betamethasone—psoriatic arthritis	0.029	0.0373	CbGbCtD
Pimozide—CYP3A4—Prednisolone—psoriatic arthritis	0.0286	0.0368	CbGbCtD
Pimozide—ABCB1—Dexamethasone—psoriatic arthritis	0.0281	0.0362	CbGbCtD
Pimozide—CYP3A4—Prednisone—psoriatic arthritis	0.027	0.0347	CbGbCtD
Pimozide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0265	0.0341	CbGbCtD
Pimozide—ABCB1—Methotrexate—psoriatic arthritis	0.0226	0.0291	CbGbCtD
Pimozide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0168	0.0217	CbGbCtD
Pimozide—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00492	0.0221	CcSEcCtD
Pimozide—Abnormal behaviour—Methylprednisolone—psoriatic arthritis	0.00412	0.0185	CcSEcCtD
Pimozide—Dysphagia—Auranofin—psoriatic arthritis	0.00329	0.0147	CcSEcCtD
Pimozide—Eosinophilia—Auranofin—psoriatic arthritis	0.00326	0.0146	CcSEcCtD
Pimozide—Pancytopenia—Auranofin—psoriatic arthritis	0.00313	0.014	CcSEcCtD
Pimozide—Weight decreased—Auranofin—psoriatic arthritis	0.00298	0.0133	CcSEcCtD
Pimozide—Agranulocytosis—Auranofin—psoriatic arthritis	0.00274	0.0123	CcSEcCtD
Pimozide—Visual impairment—Auranofin—psoriatic arthritis	0.00254	0.0114	CcSEcCtD
Pimozide—Eye disorder—Auranofin—psoriatic arthritis	0.00246	0.011	CcSEcCtD
Pimozide—Loss of libido—Methotrexate—psoriatic arthritis	0.0022	0.00986	CcSEcCtD
Pimozide—Anaemia—Auranofin—psoriatic arthritis	0.00212	0.00949	CcSEcCtD
Pimozide—Leukopenia—Auranofin—psoriatic arthritis	0.00205	0.00919	CcSEcCtD
Pimozide—Nuchal rigidity—Methotrexate—psoriatic arthritis	0.00196	0.00877	CcSEcCtD
Pimozide—Anorexia—Auranofin—psoriatic arthritis	0.00178	0.00799	CcSEcCtD
Pimozide—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.00175	0.00782	CcSEcCtD
Pimozide—Decreased appetite—Auranofin—psoriatic arthritis	0.00163	0.00729	CcSEcCtD
Pimozide—Cataract—Triamcinolone—psoriatic arthritis	0.00162	0.00724	CcSEcCtD
Pimozide—Constipation—Auranofin—psoriatic arthritis	0.0016	0.00717	CcSEcCtD
Pimozide—Amenorrhoea—Betamethasone—psoriatic arthritis	0.00159	0.00711	CcSEcCtD
Pimozide—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.00159	0.00711	CcSEcCtD
Pimozide—Urticaria—Auranofin—psoriatic arthritis	0.00149	0.00666	CcSEcCtD
Pimozide—Endocrine disorder—Prednisone—psoriatic arthritis	0.00147	0.00657	CcSEcCtD
Pimozide—Cataract—Dexamethasone—psoriatic arthritis	0.00147	0.00657	CcSEcCtD
Pimozide—Cataract—Betamethasone—psoriatic arthritis	0.00147	0.00657	CcSEcCtD
Pimozide—Amenorrhoea—Prednisone—psoriatic arthritis	0.00138	0.0062	CcSEcCtD
Pimozide—Pruritus—Auranofin—psoriatic arthritis	0.00132	0.00593	CcSEcCtD
Pimozide—Increased appetite—Prednisolone—psoriatic arthritis	0.00129	0.00579	CcSEcCtD
Pimozide—Visual disturbance—Prednisolone—psoriatic arthritis	0.00128	0.00574	CcSEcCtD
Pimozide—Diarrhoea—Auranofin—psoriatic arthritis	0.00128	0.00574	CcSEcCtD
Pimozide—Cataract—Prednisone—psoriatic arthritis	0.00128	0.00572	CcSEcCtD
Pimozide—Vomiting—Auranofin—psoriatic arthritis	0.00119	0.00533	CcSEcCtD
Pimozide—Increased appetite—Triamcinolone—psoriatic arthritis	0.00119	0.00532	CcSEcCtD
Pimozide—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00119	0.00531	CcSEcCtD
Pimozide—Speech disorder—Methotrexate—psoriatic arthritis	0.00118	0.00529	CcSEcCtD
Pimozide—Rash—Auranofin—psoriatic arthritis	0.00118	0.00529	CcSEcCtD
Pimozide—Dermatitis—Auranofin—psoriatic arthritis	0.00118	0.00528	CcSEcCtD
Pimozide—Nausea—Auranofin—psoriatic arthritis	0.00111	0.00498	CcSEcCtD
Pimozide—Increased appetite—Dexamethasone—psoriatic arthritis	0.00108	0.00483	CcSEcCtD
Pimozide—Increased appetite—Betamethasone—psoriatic arthritis	0.00108	0.00483	CcSEcCtD
Pimozide—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00107	0.00479	CcSEcCtD
Pimozide—Visual disturbance—Betamethasone—psoriatic arthritis	0.00107	0.00479	CcSEcCtD
Pimozide—Hyperkinesia—Prednisone—psoriatic arthritis	0.00106	0.00475	CcSEcCtD
Pimozide—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00101	0.00451	CcSEcCtD
Pimozide—Weight increased—Prednisolone—psoriatic arthritis	0.000955	0.00428	CcSEcCtD
Pimozide—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000954	0.00427	CcSEcCtD
Pimozide—Increased appetite—Prednisone—psoriatic arthritis	0.000939	0.00421	CcSEcCtD
Pimozide—Gynaecomastia—Methotrexate—psoriatic arthritis	0.000909	0.00407	CcSEcCtD
Pimozide—Weight increased—Triamcinolone—psoriatic arthritis	0.000878	0.00393	CcSEcCtD
Pimozide—Weight increased—Methylprednisolone—psoriatic arthritis	0.000876	0.00393	CcSEcCtD
Pimozide—Sweating—Methylprednisolone—psoriatic arthritis	0.000823	0.00369	CcSEcCtD
Pimozide—Visual impairment—Prednisolone—psoriatic arthritis	0.000809	0.00363	CcSEcCtD
Pimozide—Weight increased—Betamethasone—psoriatic arthritis	0.000797	0.00357	CcSEcCtD
Pimozide—Weight increased—Dexamethasone—psoriatic arthritis	0.000797	0.00357	CcSEcCtD
Pimozide—Weight decreased—Dexamethasone—psoriatic arthritis	0.000792	0.00355	CcSEcCtD
Pimozide—Weight decreased—Betamethasone—psoriatic arthritis	0.000792	0.00355	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—psoriatic arthritis	0.000778	0.00349	CcSEcCtD
Pimozide—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000757	0.00339	CcSEcCtD
Pimozide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000743	0.00333	CcSEcCtD
Pimozide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00072	0.00323	CcSEcCtD
Pimozide—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000715	0.0032	CcSEcCtD
Pimozide—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000702	0.00315	CcSEcCtD
Pimozide—Weight increased—Prednisone—psoriatic arthritis	0.000694	0.00311	CcSEcCtD
Pimozide—Weight decreased—Prednisone—psoriatic arthritis	0.00069	0.00309	CcSEcCtD
Pimozide—Vision blurred—Prednisolone—psoriatic arthritis	0.000689	0.00309	CcSEcCtD
Pimozide—Depression—Prednisone—psoriatic arthritis	0.000678	0.00304	CcSEcCtD
Pimozide—Visual impairment—Betamethasone—psoriatic arthritis	0.000675	0.00303	CcSEcCtD
Pimozide—Visual impairment—Dexamethasone—psoriatic arthritis	0.000675	0.00303	CcSEcCtD
Pimozide—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000675	0.00302	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—psoriatic arthritis	0.000666	0.00298	CcSEcCtD
Pimozide—Syncope—Prednisolone—psoriatic arthritis	0.000656	0.00294	CcSEcCtD
Pimozide—Eye disorder—Dexamethasone—psoriatic arthritis	0.000655	0.00293	CcSEcCtD
Pimozide—Eye disorder—Betamethasone—psoriatic arthritis	0.000655	0.00293	CcSEcCtD
Pimozide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000643	0.00288	CcSEcCtD
Pimozide—Convulsion—Prednisolone—psoriatic arthritis	0.000633	0.00284	CcSEcCtD
Pimozide—Hypertension—Prednisolone—psoriatic arthritis	0.000631	0.00283	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—psoriatic arthritis	0.000631	0.00283	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000611	0.00274	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—psoriatic arthritis	0.000605	0.00271	CcSEcCtD
Pimozide—Syncope—Triamcinolone—psoriatic arthritis	0.000603	0.0027	CcSEcCtD
Pimozide—Syncope—Methylprednisolone—psoriatic arthritis	0.000602	0.0027	CcSEcCtD
Pimozide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.0006	0.00269	CcSEcCtD
Pimozide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000591	0.00265	CcSEcCtD
Pimozide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00059	0.00264	CcSEcCtD
Pimozide—Shock—Prednisolone—psoriatic arthritis	0.000587	0.00263	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000587	0.00263	CcSEcCtD
Pimozide—Convulsion—Triamcinolone—psoriatic arthritis	0.000583	0.00261	CcSEcCtD
Pimozide—Tachycardia—Prednisolone—psoriatic arthritis	0.000582	0.00261	CcSEcCtD
Pimozide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000581	0.0026	CcSEcCtD
Pimozide—Hypertension—Triamcinolone—psoriatic arthritis	0.00058	0.0026	CcSEcCtD
Pimozide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000579	0.00259	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000577	0.00258	CcSEcCtD
Pimozide—Myalgia—Triamcinolone—psoriatic arthritis	0.000572	0.00256	CcSEcCtD
Pimozide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000571	0.00256	CcSEcCtD
Pimozide—Eye disorder—Prednisone—psoriatic arthritis	0.00057	0.00256	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—psoriatic arthritis	0.000568	0.00255	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000567	0.00254	CcSEcCtD
Pimozide—Depression—Methotrexate—psoriatic arthritis	0.000567	0.00254	CcSEcCtD
Pimozide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00056	0.00251	CcSEcCtD
Pimozide—Syncope—Betamethasone—psoriatic arthritis	0.000547	0.00245	CcSEcCtD
Pimozide—Syncope—Dexamethasone—psoriatic arthritis	0.000547	0.00245	CcSEcCtD
Pimozide—Sweating—Methotrexate—psoriatic arthritis	0.000545	0.00244	CcSEcCtD
Pimozide—Shock—Triamcinolone—psoriatic arthritis	0.00054	0.00242	CcSEcCtD
Pimozide—Insomnia—Prednisolone—psoriatic arthritis	0.00054	0.00242	CcSEcCtD
Pimozide—Shock—Methylprednisolone—psoriatic arthritis	0.000539	0.00241	CcSEcCtD
Pimozide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000537	0.00241	CcSEcCtD
Pimozide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000536	0.0024	CcSEcCtD
Pimozide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000536	0.0024	CcSEcCtD
Pimozide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000536	0.0024	CcSEcCtD
Pimozide—Mental disorder—Prednisone—psoriatic arthritis	0.000535	0.0024	CcSEcCtD
Pimozide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000534	0.00239	CcSEcCtD
Pimozide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000532	0.00238	CcSEcCtD
Pimozide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00053	0.00238	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00053	0.00238	CcSEcCtD
Pimozide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000529	0.00237	CcSEcCtD
Pimozide—Convulsion—Betamethasone—psoriatic arthritis	0.000529	0.00237	CcSEcCtD
Pimozide—Convulsion—Dexamethasone—psoriatic arthritis	0.000529	0.00237	CcSEcCtD
Pimozide—Hypertension—Betamethasone—psoriatic arthritis	0.000527	0.00236	CcSEcCtD
Pimozide—Hypertension—Dexamethasone—psoriatic arthritis	0.000527	0.00236	CcSEcCtD
Pimozide—Myalgia—Dexamethasone—psoriatic arthritis	0.000519	0.00233	CcSEcCtD
Pimozide—Myalgia—Betamethasone—psoriatic arthritis	0.000519	0.00233	CcSEcCtD
Pimozide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000512	0.00229	CcSEcCtD
Pimozide—Vision blurred—Prednisone—psoriatic arthritis	0.000501	0.00224	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.0005	0.00224	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000499	0.00223	CcSEcCtD
Pimozide—Insomnia—Triamcinolone—psoriatic arthritis	0.000496	0.00222	CcSEcCtD
Pimozide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000495	0.00222	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—psoriatic arthritis	0.000492	0.0022	CcSEcCtD
Pimozide—Anaemia—Prednisone—psoriatic arthritis	0.000491	0.0022	CcSEcCtD
Pimozide—Shock—Dexamethasone—psoriatic arthritis	0.00049	0.00219	CcSEcCtD
Pimozide—Shock—Betamethasone—psoriatic arthritis	0.00049	0.00219	CcSEcCtD
Pimozide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000488	0.00219	CcSEcCtD
Pimozide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000488	0.00219	CcSEcCtD
Pimozide—Agitation—Prednisone—psoriatic arthritis	0.000488	0.00219	CcSEcCtD
Pimozide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000486	0.00218	CcSEcCtD
Pimozide—Tachycardia—Betamethasone—psoriatic arthritis	0.000486	0.00218	CcSEcCtD
Pimozide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000481	0.00216	CcSEcCtD
Pimozide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000481	0.00216	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—psoriatic arthritis	0.000477	0.00214	CcSEcCtD
Pimozide—Syncope—Prednisone—psoriatic arthritis	0.000476	0.00213	CcSEcCtD
Pimozide—Anorexia—Dexamethasone—psoriatic arthritis	0.000475	0.00213	CcSEcCtD
Pimozide—Anorexia—Betamethasone—psoriatic arthritis	0.000475	0.00213	CcSEcCtD
Pimozide—Urticaria—Prednisolone—psoriatic arthritis	0.000474	0.00212	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000473	0.00212	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000467	0.00209	CcSEcCtD
Pimozide—Hypotension—Betamethasone—psoriatic arthritis	0.000465	0.00208	CcSEcCtD
Pimozide—Hypotension—Dexamethasone—psoriatic arthritis	0.000465	0.00208	CcSEcCtD
Pimozide—Convulsion—Prednisone—psoriatic arthritis	0.00046	0.00206	CcSEcCtD
Pimozide—Hypertension—Prednisone—psoriatic arthritis	0.000459	0.00205	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000454	0.00203	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000454	0.00203	CcSEcCtD
Pimozide—Myalgia—Prednisone—psoriatic arthritis	0.000452	0.00203	CcSEcCtD
Pimozide—Insomnia—Dexamethasone—psoriatic arthritis	0.00045	0.00202	CcSEcCtD
Pimozide—Insomnia—Betamethasone—psoriatic arthritis	0.00045	0.00202	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000449	0.00201	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—psoriatic arthritis	0.000447	0.002	CcSEcCtD
Pimozide—Urticaria—Triamcinolone—psoriatic arthritis	0.000436	0.00195	CcSEcCtD
Pimozide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000435	0.00195	CcSEcCtD
Pimozide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000433	0.00194	CcSEcCtD
Pimozide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000433	0.00194	CcSEcCtD
Pimozide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00043	0.00193	CcSEcCtD
Pimozide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00043	0.00193	CcSEcCtD
Pimozide—Shock—Prednisone—psoriatic arthritis	0.000427	0.00191	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000425	0.0019	CcSEcCtD
Pimozide—Tachycardia—Prednisone—psoriatic arthritis	0.000423	0.0019	CcSEcCtD
Pimozide—Skin disorder—Prednisone—psoriatic arthritis	0.000421	0.00189	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000419	0.00188	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—psoriatic arthritis	0.000418	0.00187	CcSEcCtD
Pimozide—Anorexia—Prednisone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Pimozide—Anaemia—Methotrexate—psoriatic arthritis	0.00041	0.00184	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—psoriatic arthritis	0.000397	0.00178	CcSEcCtD
Pimozide—Urticaria—Betamethasone—psoriatic arthritis	0.000396	0.00177	CcSEcCtD
Pimozide—Urticaria—Dexamethasone—psoriatic arthritis	0.000396	0.00177	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000395	0.00177	CcSEcCtD
Pimozide—Dizziness—Prednisolone—psoriatic arthritis	0.000395	0.00177	CcSEcCtD
Pimozide—Asthenia—Triamcinolone—psoriatic arthritis	0.000394	0.00176	CcSEcCtD
Pimozide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000393	0.00176	CcSEcCtD
Pimozide—Insomnia—Prednisone—psoriatic arthritis	0.000392	0.00176	CcSEcCtD
Pimozide—Pruritus—Triamcinolone—psoriatic arthritis	0.000388	0.00174	CcSEcCtD
Pimozide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000387	0.00174	CcSEcCtD
Pimozide—Convulsion—Methotrexate—psoriatic arthritis	0.000385	0.00172	CcSEcCtD
Pimozide—Myalgia—Methotrexate—psoriatic arthritis	0.000378	0.00169	CcSEcCtD
Pimozide—Chest pain—Methotrexate—psoriatic arthritis	0.000378	0.00169	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Pimozide—Rash—Prednisolone—psoriatic arthritis	0.000376	0.00169	CcSEcCtD
Pimozide—Dermatitis—Prednisolone—psoriatic arthritis	0.000376	0.00168	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000375	0.00168	CcSEcCtD
Pimozide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000375	0.00168	CcSEcCtD
Pimozide—Headache—Prednisolone—psoriatic arthritis	0.000374	0.00167	CcSEcCtD
Pimozide—Constipation—Prednisone—psoriatic arthritis	0.000371	0.00166	CcSEcCtD
Pimozide—Dizziness—Triamcinolone—psoriatic arthritis	0.000363	0.00163	CcSEcCtD
Pimozide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000362	0.00162	CcSEcCtD
Pimozide—Asthenia—Betamethasone—psoriatic arthritis	0.000357	0.0016	CcSEcCtD
Pimozide—Asthenia—Dexamethasone—psoriatic arthritis	0.000357	0.0016	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000355	0.00159	CcSEcCtD
Pimozide—Nausea—Prednisolone—psoriatic arthritis	0.000354	0.00159	CcSEcCtD
Pimozide—Pruritus—Betamethasone—psoriatic arthritis	0.000352	0.00158	CcSEcCtD
Pimozide—Pruritus—Dexamethasone—psoriatic arthritis	0.000352	0.00158	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—psoriatic arthritis	0.000352	0.00158	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00035	0.00157	CcSEcCtD
Pimozide—Vomiting—Triamcinolone—psoriatic arthritis	0.000349	0.00156	CcSEcCtD
Pimozide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000348	0.00156	CcSEcCtD
Pimozide—Rash—Triamcinolone—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Pimozide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Pimozide—Anorexia—Methotrexate—psoriatic arthritis	0.000345	0.00155	CcSEcCtD
Pimozide—Rash—Methylprednisolone—psoriatic arthritis	0.000345	0.00155	CcSEcCtD
Pimozide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000345	0.00155	CcSEcCtD
Pimozide—Urticaria—Prednisone—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Pimozide—Headache—Triamcinolone—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Pimozide—Headache—Methylprednisolone—psoriatic arthritis	0.000343	0.00154	CcSEcCtD
Pimozide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000341	0.00153	CcSEcCtD
Pimozide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000341	0.00153	CcSEcCtD
Pimozide—Hypotension—Methotrexate—psoriatic arthritis	0.000339	0.00152	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00033	0.00148	CcSEcCtD
Pimozide—Dizziness—Betamethasone—psoriatic arthritis	0.000329	0.00147	CcSEcCtD
Pimozide—Dizziness—Dexamethasone—psoriatic arthritis	0.000329	0.00147	CcSEcCtD
Pimozide—Insomnia—Methotrexate—psoriatic arthritis	0.000328	0.00147	CcSEcCtD
Pimozide—Nausea—Triamcinolone—psoriatic arthritis	0.000326	0.00146	CcSEcCtD
Pimozide—Nausea—Methylprednisolone—psoriatic arthritis	0.000325	0.00146	CcSEcCtD
Pimozide—Somnolence—Methotrexate—psoriatic arthritis	0.000322	0.00144	CcSEcCtD
Pimozide—Vomiting—Dexamethasone—psoriatic arthritis	0.000317	0.00142	CcSEcCtD
Pimozide—Vomiting—Betamethasone—psoriatic arthritis	0.000317	0.00142	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000315	0.00141	CcSEcCtD
Pimozide—Rash—Betamethasone—psoriatic arthritis	0.000314	0.00141	CcSEcCtD
Pimozide—Rash—Dexamethasone—psoriatic arthritis	0.000314	0.00141	CcSEcCtD
Pimozide—Dermatitis—Betamethasone—psoriatic arthritis	0.000314	0.00141	CcSEcCtD
Pimozide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000314	0.00141	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000313	0.0014	CcSEcCtD
Pimozide—Headache—Betamethasone—psoriatic arthritis	0.000312	0.0014	CcSEcCtD
Pimozide—Headache—Dexamethasone—psoriatic arthritis	0.000312	0.0014	CcSEcCtD
Pimozide—Asthenia—Prednisone—psoriatic arthritis	0.000311	0.00139	CcSEcCtD
Pimozide—Pruritus—Prednisone—psoriatic arthritis	0.000307	0.00137	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—psoriatic arthritis	0.000297	0.00133	CcSEcCtD
Pimozide—Nausea—Dexamethasone—psoriatic arthritis	0.000296	0.00132	CcSEcCtD
Pimozide—Nausea—Betamethasone—psoriatic arthritis	0.000296	0.00132	CcSEcCtD
Pimozide—Urticaria—Methotrexate—psoriatic arthritis	0.000288	0.00129	CcSEcCtD
Pimozide—Dizziness—Prednisone—psoriatic arthritis	0.000287	0.00128	CcSEcCtD
Pimozide—Vomiting—Prednisone—psoriatic arthritis	0.000276	0.00124	CcSEcCtD
Pimozide—Rash—Prednisone—psoriatic arthritis	0.000273	0.00122	CcSEcCtD
Pimozide—Dermatitis—Prednisone—psoriatic arthritis	0.000273	0.00122	CcSEcCtD
Pimozide—Headache—Prednisone—psoriatic arthritis	0.000272	0.00122	CcSEcCtD
Pimozide—Asthenia—Methotrexate—psoriatic arthritis	0.00026	0.00116	CcSEcCtD
Pimozide—Nausea—Prednisone—psoriatic arthritis	0.000258	0.00115	CcSEcCtD
Pimozide—Pruritus—Methotrexate—psoriatic arthritis	0.000256	0.00115	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000248	0.00111	CcSEcCtD
Pimozide—Dizziness—Methotrexate—psoriatic arthritis	0.00024	0.00107	CcSEcCtD
Pimozide—Vomiting—Methotrexate—psoriatic arthritis	0.00023	0.00103	CcSEcCtD
Pimozide—Rash—Methotrexate—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Pimozide—Headache—Methotrexate—psoriatic arthritis	0.000227	0.00102	CcSEcCtD
Pimozide—Nausea—Methotrexate—psoriatic arthritis	0.000215	0.000964	CcSEcCtD
